Predisposition Biomarkers Market Size & Share, by Type (Molecular, Radiographic, Histologic, Physiologic); Application (Screening, Susceptibility Analysis, Diagnostic, Prognostic, Monitoring); End-Use (Hospitals, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3090
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036.

The growth of the market can be attributed to the various advantages provided by biomarkers in reducing and monitoring the risks of several acute and chronic disease, along with aid in diagnosis and treatment. The use of biomarkers, significantly reduces the healthcare expenditure, as it monitors the health beforehand, which is estimated to boost its demand throughout the forecast period. Moreover, the rising prevalence of diseases, such as, cancer, and diabetes along with increasing government initiatives to reduce the cases of such diseases, is anticipated to promote the market growth. According to the data by the WHO, over 422 million people around the world suffer from diabetes, and it causes about 1.6 million deaths every year. Furthermore, introduction of novel and advanced technologies, such as, digital biomarkers, and escalating adoption of personalized medicines is projected to boost the market growth.


Get more information on this report: Request Free Sample PDF

Predisposition Biomarkers Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Prevalence of Chronic Diseases, Such as, Cancer, and Diabetes
  • Advancement in Diagnostic Technology
  • Ease of Availability and Use of Biomarkers

Challenges

  • Lack of Efficient Healthcare System in Developing Countries

Predisposition Biomarkers Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Predisposition Biomarkers Segmentation

The market is segmented by application into screening, susceptibility analysis, diagnostic, prognostic, monitoring, and others, out of which, the diagnostic segment is anticipated to hold a notable share in the market during the forecast period on account of increasing incidences of late diagnosis of chronic diseases, which makes their treatment more complicated and riskier. Early diagnosis can eliminate such critical cases, and improve the success rate of the treatment.

Our in-depth analysis of the global market includes the following segments:

           Type

  • Molecular
  • Radiographic
  • Histologic
  • Physiologic

             Application

  • Screening
  • Susceptibility Analysis
  • Diagnostic
  • Prognostic
  • Monitoring
  • Others

 

 

           End-User

  • Hospitals
  • Research Institutes
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Predisposition Biomarkers Industry - Regional Synopsis

Regionally, the global predisposition biomarkers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America is poised to hold largest revenue share by 2036, owing to undergoing advanced research and development in the healthcare sector along with innovative clinical experiments, and development of new diagnostic tools. The market in the Asia Pacific is estimated to witness notable growth accounting to the increasing geriatric population, along with increasing cases of various chronic diseases, such as, cancer, hypertension, and diabetes. Moreover, development in the healthcare sector, backed by government initiatives and increasing investment, is anticipated to boost the market growth.

Research Nester
Predisposition-Biomarkers-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Predisposition Biomarkers Landscape

    • Siemens Healthcare GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Danaher Corporation
    • Biomarker Technologies, Inc.
    • Almac Group Limited
    • Myriad Genetics, Inc.
    • F. Hoffmann-La Roche Ltd
    • Epigenomics AG
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN GmbH

In the News

·   March 02, 2021: Myriad Genetics to join hands with Intermountain Precision Genomics to produce germline genetic testing services.

Author Credits:  Radhika Pawar


  • Report ID: 3090
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036.

Rising prevalence of the acute and chronic disease, and growing R&D investment for medical research will impel the market growth.

North America is poised to hold largest revenue share by 2036, owing to undergoing advanced research and development in the healthcare sector along with innovative clinical experiments, and development of new diagnostic tools.

The major players in the market are Danaher Corporation, Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH and others.
Predisposition Biomarkers Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample